Literature DB >> 21791363

Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics.

Bernard Thibault1, François Harel, Anique Ducharme, Michel White, Nancy Frasure-Smith, Denis Roy, François Philippon, Paul Dorian, Mario Talajic, Marc Dubuc, Pierre Gagné, Peter G Guerra, Laurent Macle, Léna Rivard, Paul Khairy.   

Abstract

BACKGROUND: Heart failure is considered an epidemic of the modern era. In selected candidates on optimal medical therapy, cardiac resynchronization therapy (CRT) has emerged as a valuable adjunctive treatment. Despite its demonstrated salutary effects on clinical evolution, left ventricular (LV) function, and overall survival, at least 30% of patients fail to respond to CRT.
METHODS: The Greater Evaluation of Resychronization Therapy for Heart Failure (GREATER-EARTH) (ClinicalTrials.gov Identifier NCT00901212) is a randomized, double-blind, multicentre study involving 11 centres across Canada and compares LV CRT with biventricular CRT in patients with severe LV dysfunction and a QRS duration>120 ms.
RESULTS: This article describes the rationale and design of the study and presents the baseline characteristics of all randomized patients. The primary outcome consists of the effects of CRT on submaximal exercise tolerance (treadmill test), and secondary outcomes explore mechanisms of asynchrony and effects of CRT on asynchrony and LV function.
CONCLUSION: The study was initiated in November 2003, with the last patient randomized on February 12, 2009. As expected, follow-up was in February 2010 and the results are presently being analyzed in March 2010.
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21791363     DOI: 10.1016/j.cjca.2011.03.010

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Diastolic asynchrony and myocardial dysfunction in patients with univentricular heart after Fontan operation.

Authors:  Wei Hui; Mohamed Y Abd El Rahman; Rita Schuck; Axel Rentzsch; Moustafa Yigitbasi; Stanislav Ovroutski; Fatima Lunze; Felix Berger; Hashim Abdul-Khaliq
Journal:  J Echocardiogr       Date:  2013-09-06

2.  Atrial synchronous left ventricular only pacing with VDD pacemaker system - a cost effective alternative to conventional cardiac resynchronization therapy.

Authors:  Arun Gopi; Gomathi Sundar; Sachin Yelagudri; Krishnamohan Lalukota; C Sridevi; Calambur Narasimhan
Journal:  Indian Heart J       Date:  2014-12-22

Review 3.  Cardiac resynchronization therapy in patients with mild heart failure is a reversal therapy.

Authors:  Sadeq Ali-Hassan-Al-Saegh; Seyed Jalil Mirhosseini; Ali Akbar Karimi-Bondarabadi; Azadeh Sahidzadeh; Parisa Mahdavi; Mahbube Tahernejad; Safieyehsadat Heydari; Alexander Weymann; Mohamed Zeriouh; Anton Sabashnikov; Aron-Frederik Popov
Journal:  Indian Heart J       Date:  2016-08-25

4.  Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation.

Authors:  Helder Pereira; Tom A Jackson; Simon Claridge; Jonathan M Behar; Cheng Yao; Benjamin Sieniewicz; Justin Gould; Bradley Porter; Baldeep Sidhu; Jaswinder Gill; Steven Niederer; Christopher A Rinaldi
Journal:  Cardiol Res Pract       Date:  2019-02-21       Impact factor: 1.866

5.  Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.

Authors:  Valéry Legris; Bernard Thibault; Jocelyn Dupuis; Michel White; Anita W Asgar; Annik Fortier; Céline Pitre; Nadia Bouabdallaoui; Christine Henri; Eileen O'Meara; Anique Ducharme
Journal:  ESC Heart Fail       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.